Terray Therapeutics CEO Jacob Berlin (L) and CFO and COO Eli Berlin

Months af­ter adding $60M to cof­fers, AI start­up Ter­ray nabs dis­cov­ery pact with Google's Cal­i­co

A small Cal­i­for­nia biotech emerged from stealth last year to go af­ter drug dis­cov­ery’s “da­ta prob­lem,” and now the AI out­fit has an­nounced its first pub­lic part­ner­ship.

Ter­ray Ther­a­peu­tics put out word Wednes­day that it reached a deal with Cal­i­co Life Sci­ences, the Google-backed an­ti-ag­ing biotech co-found­ed by in­dus­try leg­end,  bil­lion­aire and cur­rent CEO Art Levin­son, the for­mer head over at Genen­tech and cur­rent chair­man at Ap­ple.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.